由于肥胖或与肥胖相关的问题而有病假或有病假风险的人参加了新的职业康复(VR)。该研究旨在检查参与者健康相关生活质量(HRQoL)的结果变化,体重指数(BMI),恢复工作自我效能感(RTWSE),参与12个月VR计划后的工作能力量表(WAS)和工作参与程度(DWP)。次要目的是在12个月的随访中检查结果变化与HRQoL之间的关联。用HRQoL15D仪器(15D)测量。
这项前瞻性观察研究包括95名参与者。为期一年的多学科VR计划,包括综合工作和生活方式干预,包括4周的住院患者随访5次会议。使用配对样本t检验检查HRQoL的变化,BMI,RTWSE,WAS,基线和12个月随访之间的DWP。多元线性回归分析探讨了HRQoL变化与结果变量之间的关联。
参与者在HRQoL方面实现了统计学上的显着变化(2.57,95%CI:1.35至3.79),BMI(-2.33,95%CI:-3.10至-1.56),RTWSE(15.89,95%CI:4.07至27.71),WAS(1.51,95%CI:0.83至2.20)和DWP(18.69,95%CI:8.35至29.02)。12个月时,发现HRQoL和BMI之间存在显着关联(B=-0.34,95%CI:-0.65至-0.04),RTWSE(B=0.02,95%CI:0.004至0.04),WAS(B=0.91,95%CI:0.55至1.28),DWP(B=-0.02,95%CI:-0.04至0.001)和缺勤(B=-0.01,95%CI:-0.02至-0.002)。回归模型解释了71.8%的HRQoL方差。
结果表明HRQoL有积极变化,BMI,RTWSE,从基线到12个月随访的WAS和DWP。12个月随访时与HRQoL相关的因素是BMI降低,增加RTWSE,提高了WAS,减少了缺勤。建议进行未来的研究,以对肥胖者进行生活方式干预的VR计划。
挪威区域医学与健康研究伦理委员会(REC)2017/573,临床试验NCT03286374,注册182017年9月。https://clinicaltrials.gov/ct2/results?cond=肥胖&term=Anita+Dyb+Linge&cntry=NO&state=&city=&dist=.
People on or at risk of sick leave from work due to obesity or obesity-related problems participated in a new vocational rehabilitation (VR). The study aimed to examine the outcome changes in the participants\' health-related quality of life (HRQoL), body mass index (BMI), return to work self-efficacy (RTWSE), work ability scale (WAS) and degree of work participation (DWP) after their participation in the 12-month VR programme. The secondary aim was to examine associations between the outcome changes and HRQoL at 12-month follow-up, measured with the HRQoL 15D instrument (15D).
This prospective observational study included 95 participants. The one-year multidisciplinary VR programme with an integrated work and lifestyle intervention included 4 weeks of inpatient stay followed-up by 5 meetings. A paired sample t-test was used to examine changes in HRQoL, BMI, RTWSE, WAS, and DWP between baseline and the 12-month follow-up. Multiple linear regression analyses explored associations between changes in HRQoL and the outcome variables.
The participants achieved statistically significant changes in HRQoL (2.57, 95% CI: 1.35 to 3.79), BMI (- 2.33, 95% CI: - 3.10 to - 1.56), RTWSE (15.89, 95% CI: 4.07 to 27.71), WAS (1.51, 95% CI: 0.83 to 2.20) and DWP (18.69, 95% CI: 8.35 to 29.02). At 12 months, a significant association was found between HRQoL and BMI (B = - 0.34, 95% CI: - 0.65 to - 0.04), RTWSE (B = 0.02, 95% CI: 0.004 to 0.04), WAS (B = 0.91, 95% CI: 0.55 to 1.28), DWP (B = - 0.02, 95% CI: - 0.04 to 0.001) and work absence (B = - 0.01, 95% CI: - 0.02 to - 0.002). The regression model explained 71.8% of the HRQoL variance.
The results indicated positive changes in HRQoL, BMI, RTWSE, WAS and DWP from baseline to the 12-month follow-up. Factors associated with HRQoL at the 12-month follow-up were decreased BMI, increased RTWSE, improved WAS and reduced work absence. Future studies examining VR programmes with lifestyle interventions for people with obesity are recommended.
Norwegian Regional Committee for Medical and Health Research Ethics (REC) 2017/573, Clinical Trials NCT03286374 , registered 18. September 2017. https://clinicaltrials.gov/ct2/results?cond=Obesity&term=Anita+Dyb+Linge&cntry=NO&state=&city=&dist=.